Podcast
Questions and Answers
What was the primary cardiovascular endpoint of the study?
What was the primary cardiovascular endpoint of the study?
- Improvement in insulin sensitivity
- Reduction in LDL cholesterol levels
- Reduction in overall mortality rate
- Time to first occurrence of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke (correct)
What was the mean weight loss observed in the semaglutide group?
What was the mean weight loss observed in the semaglutide group?
- 5.2%
- 3.8%
- 9.4% (correct)
- 12.1%
What was the design of the trial?
What was the design of the trial?
- Single-center, open-label, non-randomized
- Multicenter, single-blind, non-randomized
- Single-center, double-blind, randomized
- Multicenter, double-blind, randomized, placebo-controlled (correct)
What did the study emphasize about the specific objectives?
What did the study emphasize about the specific objectives?
What did the study mention about the use of semaglutide?
What did the study mention about the use of semaglutide?
What was the duration of the multicenter, double-blind, randomized, placebo-controlled trial?
What was the duration of the multicenter, double-blind, randomized, placebo-controlled trial?
What were the specific secondary endpoints discussed in the study?
What were the specific secondary endpoints discussed in the study?
What was the mean weight loss observed in the placebo group?
What was the mean weight loss observed in the placebo group?
What was the focus of the study in terms of the participants' health status?
What was the focus of the study in terms of the participants' health status?
What did the study emphasize about the use of semaglutide in reducing cardiovascular risk?
What did the study emphasize about the use of semaglutide in reducing cardiovascular risk?